-
Cobra Bio, Karolinska Inst. to Develop COVID-19 Vaccine
contractpharma
March 31, 2020
Cobra Biologics, an international contract development and manufacturing organization (CDMO) for biologics and pharmaceuticals, and the Karolinska Institutet ...
-
Moderna to pause certain clinical development activities amid Covid-19
pharmaceutical-technology
March 31, 2020
Biotechnology firm Moderna has provided an update on the impact of the Covid-19 pandemic on its clinical development activities and business operations.
-
Researcher in India designs potential Covid-19 vaccine candidates
pharmaceutical-technology
March 31, 2020
A researcher at University of Hyderabad (UoH) in India has designed potential Covid-19 vaccine candidates referred to as T-cell epitopes.
-
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
pharmaceutical-technology
March 31, 2020
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and Human Service (HSS)’s Biomedical Advanced Research and Development Authority (BARDA).
-
COVID-19: UK commits £210m as pharmacist warns Brits not to stockpile Ventolin inhalers
pharmatimes
March 30, 2020
Amidst the growing “unprecedented circumstances”, the UK government has said it will contribute £210 million toward international efforts aimed at finding a vaccine against the novel virus.
-
Sartorius Supports Development of Vaccine Candidate against Coronavirus
americanpharmaceuticalreview
March 30, 2020
Sartorius has supported CanSino Biologics and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences ...
-
Biopharma industry leaders collaborate to combat COVID-19
europeanpharmaceuticalreview
March 30, 2020
The International Federation of Pharmaceutical Manufacturers and Associations has announced that the biopharma industry has responding swiftly to the COVID-19 pandemic and will further increase its efforts.
-
UK pledges £210m to CEPI for Covid-19 vaccine development
pharmaceutical-technology
March 30, 2020
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government to support efforts to develop a Covid-19 vaccine.
-
Dynavax teams up with CEPI for Covid-19 vaccine
pharmaceutical-technology
March 30, 2020
Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
-
Hoth Therapeutics announces agreement to joint development for a self-assembling vaccine (SAV) for the potential prevention of coronavirus
pharmaceutical-business-review
March 27, 2020
Hoth Therapeutics has reached an agreement with Voltron Therapeutics to form a joint venture entity, to be named HaloVax, to commence preclinical studies.